Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance

• Luis Manso,

  Affiliation Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain

  ⨯
• Silvana Mourón,

  Affiliation Breast Cancer Clinical Research Unit, CNIO—Spanish National Cancer Research Center, Madrid, Spain

  ⨯
• Michael Tress,

  Affiliation Structural Computational Biology Group, CNIO—Spanish National Cancer Research Center, Madrid, Spain

  ⨯
• Gonzalo Gómez-López,

  Affiliation Bioinformatics Unit, CNIO—Spanish National Cancer Research Center, Madrid, Spain

  ⨯
• Manuel Morente,

  Affiliation Biobank, CNIO—Spanish National Cancer Research Center, Madrid, Spain

  ⨯
• Eva Ciruelos,

  Affiliation Breast Cancer Clinical Research Unit, CNIO—Spanish National Cancer Research Center, Madrid, Spain

  ⨯
• Miriam Rubio-Camarillo,

  Affiliation Bioinformatics Unit, CNIO—Spanish National Cancer Research Center, Madrid, Spain

  ⨯
• Jose Luis Rodriguez-Peralto,

  Affiliation Pathology Department, Hospital 12 de Octubre, Madrid, Spain

  ⨯
• Miguel A. Pujana,

  Affiliation Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research, Barcelona, Spain

  ⨯
• David G. Pisano,

  Affiliation Bioinformatics Unit, CNIO—Spanish National Cancer Research Center, Madrid, Spain

  ⨯
• Miguel Quintela-Fandino

  * E-mail: mquintela@cnio.es

  Affiliation Breast Cancer Clinical Research Unit, CNIO—Spanish National Cancer Research Center, Madrid, Spain

  ⨯